GOLDMAN SACHS GROUP INC - AVANIR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVANIR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$6,958,000
-64.5%
410,476
-75.0%
0.00%
-66.7%
Q3 2014$19,610,000
+272.2%
1,645,185
+76.1%
0.01%
+500.0%
Q2 2014$5,269,000
-52.8%
934,255
-69.3%
0.00%
-75.0%
Q1 2014$11,159,000
+125.8%
3,040,582
+106.7%
0.00%
+300.0%
Q4 2013$4,943,000
+598.2%
1,471,241
+779.0%
0.00%
Q3 2013$708,000
-29.2%
167,381
-23.0%
0.00%
Q2 2013$1,000,000
+609.2%
217,376
+303.8%
0.00%
Q4 2012$141,000
-73.9%
53,839
-68.1%
0.00%
Q3 2012$540,000
+23.0%
168,628
+50.5%
0.00%
Q2 2012$439,000
+177.8%
112,009
+142.1%
0.00%
Q1 2012$158,00046,2670.00%
Other shareholders
AVANIR PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 2,295,000$38,900,0006.85%
Baker Brothers Advisors 38,513,713$652,807,0006.66%
Realm Partners LLC 300,000$5,085,0003.92%
Miura Global Management 2,758,000$46,748,0003.52%
WATER ISLAND CAPITAL LLC 10,612,846$179,887,740,0003.00%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 641,056$10,866,0002.72%
Verition Fund Management LLC 703,900$11,931,0002.67%
GLAZER CAPITAL, LLC 1,004,815$17,032,0002.46%
GARDNER LEWIS ASSET MANAGEMENT L P 716,994$12,153,0002.45%
Rock Springs Capital Management LP 1,100,000$18,645,0002.18%
View complete list of AVANIR PHARMACEUTICALS INC shareholders